Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

https://www.fosunpharma.com/en/

Latest From Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

US-China Decoupling Gets On Biotech's Nerves

The Biden Administration’s latest Executive Order is aimed at shoring up investment in the US and securing supply chains for pharma and biotech products and is already impacting China's CDMO sector, but the long-term impact may be more nuanced, experts predict.

Supply Chain Policy

Henlius Forges Ahead With US PD-1 Plans Despite Peers' Setbacks

The latest step by the Chinese drug maker to support its international ambitions is a bridging study in the US, which will evaluate its PD-1 contender serplulimab against Roche’s PD-L1-targeted Tecentriq.

China Clinical Trials

The Emergence Of A New Medicinal Platform: mRNA

In the first of a three-part series on the evolution of mRNA manufacturing, this article looks back to before the pandemic, when dogged mRNA researchers and entrepreneurs labored in obscurity pursuing the dream of revolutionizing health care by commandeering the body’s own protein building process to generate quicker, cheaper vaccines and therapeutics. Then the mRNA COVID-19 vaccines stunned the world.

Manufacturing Coronavirus COVID-19

Mixed Results For China’s First Home-Grown COVID Antiviral

A preliminary analysis of Russian Phase III results for azvudine, China's first home-grown antiviral for COVID-19, shows it reached two primary endpoints, but a separate Chinese study produced mixed results.

China Clinical Trials
See All

Company Information

  • Industry
  • Biotechnology
  • In Vitro Diagnostics
  • Medical Devices
  • Pharmaceuticals
  • Services
  • Research, Analytical Equipment & Supplies
    • PCR & Amplification Tools
  • Pharmaceuticals
    • Vaccines
  • Medical Devices
    • Diagnostic Equipment & Supplies
    • Surgical Equipment & Devices
  • Other Names / Subsidiaries
    • Ahon Pharmaceutical Co., Ltd.
    • Fosun Pharma Kite Biotechnology Co. Ltd.
    • Guilin Pharma
    • Jiangsu Wanbang Biopharmaceutical Group Co., Ltd.
    • Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
    • Shenyang Hongqi Pharmaceuticals Co., Ltd.
UsernamePublicRestriction

Register